Challenge Facility for Civil Society
The Challenge Facility for Civil Society has launched Round 7
The Challenge Facility for Civil Society (CFCS) provides grants to technically sound and innovative interventions to support the engagement of communities in national tuberculosis (TB) responses, especially in countries supported by the Global Fund to Fight HIV, Tuberculosis, and Malaria. In the last seven years, the CFCS has given voice to community-based organizations and provided support to those engaged in advocacy and social mobilization activities. The goal has been to empower communities to be a part of all the steps in the fight against TB. Six rounds of grants have been awarded since 2007, with more than US$ 2.1 million to 121 grantees in 41 countries.
The focus of the current call (Round 7) is to invest significantly in community responses that are integrated and are part of a comprehensive response to TB.
To contribute to its vision of strengthened comprehensive TB responses that engage and are accountable to communities and its goal to strengthen community responses that are integrated and part of a comprehensive response to TB the 3 primary objectives of Round 7 are to:
- Strengthen existing or new national level TB constituencies that engage, represent and are accountable to communities.
- Reinforce the capacities & responses of local communities who are part of the TB response.
- Tighten linkages, collaboration and coordination between communities and government.
A strengthened, integrated and comprehensive TB response that explicitly responds to community needs.
Effective community engagement, strengthened representation and subsequent accountability to communities in the national TB response, as well as strengthened linkages and partnerships between community groups, public agencies, the Global Fund Country Coordination Mechanism and other actors.
Documented best practices and evidence based recommendations to enhance community responses that are integrated & part of a comprehensive response to TB, which can be adapted and replicated in other countries.
For more information on Round 7 please click here.
In This Section
A Lilly Foundation grant in association with the Lilly MDR-TB Partnership